Objective
This research addresses a clinical problem with an innovative approach. Pancreatic cancer is one of the deadliest cancers and only 10% of patients survive 5 years after diagnosis. To find better therapies, we need patient-specific models that mimic the biology of tumour tissues and target interactions between different cell types. We will develop a controllable platform for modelling the human disease in the laboratory. We will use our new platform to discover better ways of treating the disease.
Fields of science
Keywords
Programme(s)
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Funding Scheme
HORIZON-ERC-POC - HORIZON ERC Proof of Concept GrantsHost institution
LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV
Net EU contribution
€ 150 000,00
Address
HOHE STRASSE 6
01069 Dresden
Germany
01069 Dresden
Germany
Region
Sachsen
Dresden
Dresden, Kreisfreie Stadt
Activity type
Research Organisations
Links
Total cost
No data